Grant Support

Faculty/Role Funding Agency Title
Conway, James H (PI) Sanofi Pasteur Surveillance for Rates of Pertussis Disease Among Persons birth through 59 Months of Age Receiving Pentacel or Other Pertussis Vaccines
Conway, James H (co-I) with
Temte, Jon (PI)
DHHS, PHS, Centers for Disease Control ORCHARDS: ORegon CHild Absenteeism due to Respiratory Disease Study
Henderson, Sheryl L (PI) Wisconsin Department of Health Services HIV/AIDS Comprehensive Care Program
Klein, Bruce S (PI) Wisconsin Alumni Research Foundation Targeting Hybrid Histidine Kinase for Broad-Spectrum Antifungal Therapy
Klein, Bruce S (PI) Wisconsin Alumni Research Foundation Anti-Fungal Drug Discovery
Klein, Bruce S (PI)
Wüethrich, Marcel (co-I)
DHHS, PHS, National Institutes of Health Mechanisms of Anti-Fungal Vaccine Immunity
Klein, Bruce S (PI) DHHS, PHS, National Institutes of Health Tracking Anti-Fungal CD4+ T Cells In Vivo
Klein, Bruce S (PI) American Heart Association Greater Midwest Affiliate Group III Hybrid Histidine Kinases: A Novel Drug Target for the Treatment of Cardiac Fungal Infections (S. Lawry)
Klein, Bruce S (PI) Pediatric Infectious Diseases Society Understanding Fungal Morphogenesis and Dissemination Using In Vivo Imaging of a Larval Zebrafish Model (J.M. Davis)
Klein, Bruce S (PI) Wisconsin Alumni Research Foundation Strategies for Assessing and Inducing Immunity to Life-Threatening Fungal Infections
Klein, Bruce S (PI) Wisconsin Alumni Research Foundation Attend the Gordon Research Conference "Immunology of Fungal Infections" in Galveston, TX
Klein, Bruce S (PI) DHHS, PHS, National Institutes of Health T32 - Microbes in Health and Disease
Klein, Bruce S (PI) Lucigen CLIA-waived Point of Care Tests for Infection by Coccidioides, Blastomyces and Histoplasma.
Klein, Bruce S (PI) DHHS, PHS, National Institutes of Health Molecular Pathogenesis and Blastomyces Adherence
Klein, Bruce S (PI) UWF - Wisconsin Partnership Program MERC Wisconsin Center for Infectious Diseases
Klein, Bruce S (co-PI with
Osorio, Jorge)
US Geological Survey Oral Vaccines and Delivery Methods for Controlling Disease in Bats
Klein, Bruce S (core B co-leader) with
Andes, David (PI)
National Institutes of Health Anti-Fungal Drug Discovery
Wald, Ellen R (PI) Hoffmann-Laroche, Inc. BP28947 - "A Screening Protocol to Assess Adult and Adolescent Individuals with Down Syndrome for Eligibility to Participate in an Upcoming Study to Evaluate the Efficacy, Safety and Tolerability of RO5186582"
Wald, Ellen R (PI) with
DeMuri, Gregory P and
Gern, James E (co-Is)
DHHS, PHS, National Institutes of Health Sinusitis in Children and the Nasopharyngeal Microbiome
Wald, Ellen R (PI) DHHS, PHS, National Institutes of Health An Interactive Web-Based Intervention to Achieve Healthy Weight in Young Children
Wald, Ellen R (PI) Glaxosmithkline GSK 112957 (HIB-097)
Wald, Ellen R (PI) Cubist Pharmaceuticals, Inc. CUBEXA-01: A Multicenter, Randomized, Double-Blinded Comparative Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Ceftaroline or Daptomycin Versus Active Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis Due to Gram-Positive Organisms
Wald, Ellen R (PI) Glaxosmithkline GSK MMR0160
Wald, Ellen R (PI)
DeMuri, Gregory P (co-I)
Thrasher Research Fund Short (5 days) versus Long (14 days) Duration of Antimicrobial Therapy for Acute Bacterial Sinusitis in Children
Wald, Ellen R (PI) Glaxosmithkline Immunogenicity and Safety Study of GSK Biologicals 'Infanrix hexa' at 2, 4 and 6 Months of Age in Healthy Infants.
Wald, Ellen R (co-I) with
Baker, Mei Wang;
Laffin, Jennifer J;
Rice, Gregory;
Scott Schwoerer,
Jessica A (collaborators) and
Seroogy, Christine (PI)
Wisconsin Partnership Program Improved Health Care Delivery to Wisconsin Amish Infants
Wüethrich, Marcel (PI)
Klein, Bruce S (co-I)
DHHS, PHS, National Institutes of Health Regulation of Vaccine-Induced Anti-Fungal T17 Cells